Full and Booster Doses of SARS-CoV-2 mRNA-1273 Vaccine Increase Waning Antibody Levels After Completed Vaccination Among Dialysis Patients at a Large Dialysis Organization
Linda H Ficociello,1 Joanna Willetts,1 Claudy Mullon,1 Curtis Johnson,2 Michael S Anger,1 Jeffrey L Hymes1 1Global Medical Office, Fresenius Medical Care, Waltham, MS, USA; 2Spectra Laboratories, Southaven, MS, USACorrespondence: Jeffrey L Hymes, Fresenius Medical Care, 1000 Corporate Centre Drive,...
Main Authors: | Ficociello LH, Willetts J, Mullon C, Johnson C, Anger MS, Hymes JL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-11-01
|
Series: | International Journal of Nephrology and Renovascular Disease |
Subjects: | |
Online Access: | https://www.dovepress.com/full-and-booster-doses-of-sars-cov-2-mrna-1273-vaccine-increase-waning-peer-reviewed-fulltext-article-IJNRD |
Similar Items
-
Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
by: Sammy Patyna, et al.
Published: (2022-04-01) -
Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
by: Georg Beilhack, et al.
Published: (2022-06-01) -
Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
by: Rituparna Das, et al.
Published: (2023-01-01) -
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01) -
Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave
by: Georg Beilhack, et al.
Published: (2023-06-01)